Sci Pharmtech Corp.TWSE: 4119

SCI Pharmtech To announce that the Company signed a medium-term loan agreement with the bank.

· Issued by Sci Pharmtech Corp.
Close
Today's Information

Provided by: SCI Pharmtech, Inc.
SEQ_NO 1 Date of announcement 2022/01/26 Time of announcement 16:53:36
Subject
 To announce that the Company signed a medium-term
loan agreement with the bank.
Date of events 2022/01/26 To which item it meets paragraph 10
Statement
1.Date of occurrence of the event:2022/01/26
2.Counterparty to the contract or commitment:
Mega International Commercial Bank Co., Ltd Taohsin Branch
3.Relationship with the Company: none
4.Starting and ending dates (or rescission date) of the
contract or commitment:
Five years right after first drawdown
5.Major content (not applicable where rescinded):
NT$1 billion medium-term loan
6.Restrictive covenants (not applicable where rescinded):
The borrowing must comply with the relevant regulations of the ��Accelerated
Investment Project Loan for Enterprises Investing in Taiwan��.
7.Commitment (not applicable where rescinded):none
8.Any other important agreement (not applicable where rescinded):
With the land No. 560 in the Luzhu District, Taoyuan City and its buildings,
No. 207-1, 207-2, 207-3, 207-4 and 207-5, as collaterals, the amount of
pledge set at NTD1,032,700,000.
9.Effect on company finances and business:none
10.Concrete purpose/objective:For the capex of Guanyin Plant
11.Any other matters that need to be specified:none